Testing effectiveness (Phase 2)Study completedNCT04547127
What this trial is testing
Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recovered From Coronavirus Disease 2019 (COVID-19)
Who this might be right for
COVID-19
Instituto Grifols, S.A. 200